Europe Hemostasis Analyzers Market

Market Introduction

Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners.  Constant technical advancement has led to the launch of many innovative drugs, and instruments such as high-performance hemostasis analyzers are projected to fuel demand growth for hemostasis analyzers.

The report provides trends prevailing in the Europe hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.

After Asia, the European region is highly affected by the outbreak of the COVID-19 pandemic. Countries like Italy, Spain, the UK, Germany, France, and other European counties such as Russia, Switzerland are highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries, and the number of deaths is also high. According to the International Health Regulation, the current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern. The blood clots associated with the COVID19 infection and the specific vaccines are among the critical concern. However, the incidence of blood clotting due to the COVID19 vaccine is rare, and the region's regulatory agencies in the region have confirmed it is closely monitored. Therefore, it is expected that the growth of the market is likely to be slower in the following few years.

Europe Hemostasis Analyzers Strategic Insights

Strategic insights for the Europe Hemostasis Analyzers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Hemostasis Analyzers Report Scope

Europe Hemostasis Analyzers Regional Insights

The geographic scope of the Europe Hemostasis Analyzers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe hemostasis analyzers market in the Europe is expected to grow from US$ 1,057.50 million in 2021 to US$ 1,970.20 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.  Automation is emerging as an approach to minimize human involvement in laboratory processes. The automation of routine laboratory procedures with the help of dedicated workstations and system software helps increase efficiency and reduce human errors. Laboratories are increasingly adopting laboratory information management systems (LIMS) and other automation tools to maintain stringent regulatory compliance, increase efficiency and productivity, and enhance data security and integrity. As per the study published in the Journal of Lab Automation, the error frequencies in fully automated, semiautomated, and manual operations are 1–5%, 1–10%, and 10–30%, respectively. Moreover, high volumes of data generated by laboratory systems are triggering the demand for effective data processing, analysis, and sharing methods, thereby highlighting the need for efficient and cost-effective solutions such as the LIMS.

Key Market Segments

In terms of product type, the laboratory analyzer segment accounted for the largest share of the Europe hemostasis analyzers market in 2020.  In terms of test, the d-dimer test segment accounted for the largest share of the Europe hemostasis analyzers market in 2020. In terms of end user, the hospital/clinics segment accounted for the largest share of the Europe hemostasis analyzers market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Europe hemostasis analyzers market in Europe are company websites, annual reports, financial reports, national government documents, and statistical databases, among others. Major companies listed in the report are Siemens Healthineers AG , Abbott  , Sysmex Corporation , Nihon Kohden Corporation ,THERMO FISHER SCIENTIFIC INC. ,HOFFMANN-LA ROCHE LTD. , Instrumentation Laboratory Company.

Reasons to buy report

• To understand the Europe hemostasis analyzers market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe hemostasis analyzers markets.
• Efficiently plan M&A and partnership deals in the Europe hemostasis analyzers market by identifying market segments with the most promising probable sales
• Helps to make knowledgeable business decisions from a perceptive and comprehensive analysis of the market performance of various segments for the Europe hemostasis analyzers market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in the Europe region.

Europe Hemostasis Analyzers Market Segmentation

By Product Type

• Laboratory Analyzer
  • Automated Systems
  • Semi-Automated Systems
  • Manual Systems
• Point-of-Care Testing Systems

By Test

• Activated Partial Thromboplastin Time
• D-Dimer Test
• Fibrinogen Test
• Prothrombin Time (PT) Test
• Others

By End User

• Hospitals/ Clinics
• Independent Diagnostic Laboratories
• Home Care Setting
• Others

By Country

• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Companies Mentioned -

•  Siemens Healthineers AG
• Abbott 
•  Sysmex Corporation
• Nihon Kohden Corporation
• THERMO FISHER SCIENTIFIC INC.
• HOFFMANN-LA ROCHE LTD.
• Instrumentation Laboratory Company